1. Home
  2. INAB vs WETH Comparison

INAB vs WETH Comparison

Compare INAB & WETH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INAB
  • WETH
  • Stock Information
  • Founded
  • INAB 2016
  • WETH 1992
  • Country
  • INAB United States
  • WETH China
  • Employees
  • INAB N/A
  • WETH N/A
  • Industry
  • INAB Biotechnology: Pharmaceutical Preparations
  • WETH
  • Sector
  • INAB Health Care
  • WETH
  • Exchange
  • INAB Nasdaq
  • WETH Nasdaq
  • Market Cap
  • INAB 9.1M
  • WETH 10.9M
  • IPO Year
  • INAB 2021
  • WETH N/A
  • Fundamental
  • Price
  • INAB $2.00
  • WETH $1.31
  • Analyst Decision
  • INAB Strong Buy
  • WETH
  • Analyst Count
  • INAB 2
  • WETH 0
  • Target Price
  • INAB $108.00
  • WETH N/A
  • AVG Volume (30 Days)
  • INAB 45.9K
  • WETH 266.7K
  • Earning Date
  • INAB 11-11-2025
  • WETH 09-10-2025
  • Dividend Yield
  • INAB N/A
  • WETH N/A
  • EPS Growth
  • INAB N/A
  • WETH N/A
  • EPS
  • INAB N/A
  • WETH 0.52
  • Revenue
  • INAB N/A
  • WETH $42,280,373.00
  • Revenue This Year
  • INAB N/A
  • WETH N/A
  • Revenue Next Year
  • INAB N/A
  • WETH N/A
  • P/E Ratio
  • INAB N/A
  • WETH $2.56
  • Revenue Growth
  • INAB N/A
  • WETH 6.48
  • 52 Week Low
  • INAB $1.91
  • WETH $0.76
  • 52 Week High
  • INAB $16.70
  • WETH $2.96
  • Technical
  • Relative Strength Index (RSI)
  • INAB 39.35
  • WETH 66.57
  • Support Level
  • INAB $1.91
  • WETH $1.15
  • Resistance Level
  • INAB $2.20
  • WETH $1.23
  • Average True Range (ATR)
  • INAB 0.11
  • WETH 0.15
  • MACD
  • INAB -0.01
  • WETH 0.02
  • Stochastic Oscillator
  • INAB 23.08
  • WETH 76.60

About INAB IN8bio Inc.

IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.

About WETH Wetouch Technology Inc.

Wetouch Technology Inc is a touch panel supplier focused on R & D, production and sales of touch screen products. It offers touchscreens for a variety of applications, including GPS/car entertainment panels for automotive industry, industrial human-machine interface, financial and banking terminals, point of sale, lottery and gaming machines, smart home, robots and charging stations. The company sells touchscreen products both domestically in China and internationally, covering the majority of areas in China, Taiwan, South Korea, and Germany.

Share on Social Networks: